Tech Company Financing Transactions
Sexton Biotechnologies Funding Round
Sexton Biotechnologies closed a $5 million funding round on 9/25/2019. Investors included BioCrossroads, BioLife Solutions and Casdin Capital.
Transaction Overview
Company Name
Announced On
9/25/2019
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Proceeds Purpose
This new round of investment gives us additional resources to further develop and support our unique products while strengthening our connections in the thriving Indiana life sciences sector through the relationship with BioCrossroads.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Indianapolis, IN 46202
USA
Indianapolis, IN 46202
USA
Phone
Undisclosed
Email Address
Overview
Sexton Biotechnologies is a revenue stage, biotechnology company focused on the development and sales of bioproduction tools for cell and gene therapy founded in 2019 as a spin out of Cook Regentec, a business and medical technology incubator located in Indianapolis, IN.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
President
Sean Werner
Browse more venture capital transactions:
Prev: 9/25/2019: YUR venture capital transaction
Next: 9/25/2019: Fivetran venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs